6-amino-2-n-pentylthiobenzothiazole has been researched along with Candida Infection in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bujdáková, H; Melkusová, S; Mikami, Y; Myoken, Y; Volleková, A | 1 |
Bujdáková, H; Fábry, S; Gáborová, S; Klobusický, M; Kuchta, T; Volleková, A | 1 |
2 other study(ies) available for 6-amino-2-n-pentylthiobenzothiazole and Candida Infection
Article | Year |
---|---|
The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Thiazoles | 2004 |
Inhibition of germ tube formation, filamentation and ergosterol biosynthesis in Candida albicans treated with 6-amino-2-n-pentylthiobenzothiazole.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Culture Media; Ergosterol; Humans; Thiazoles | 1999 |